Analyst consensus rating
BioHarvest Sciences Analyst Rating: none
BHST is rated none by 4 analysts with a $10.50 target. As of 2026-09-02.
Direct answer
BioHarvest Sciences's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.50.
Forecast evidence checked September 2, 2026.
Get free BioHarvest Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.92
- Average price target
- $10.50
- High price target
- $15.00
- Low price target
- $5.00
- Low target gap
- +160.4%
- Target upside
- +446.9%
- High target gap
- +681.3%
- Target range width
- 520.8%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioHarvest Sciences?
BioHarvest Sciences has a verified none consensus. The same dataset has an average price target of $10.50.
How far are BioHarvest Sciences's low and high targets from the recorded price?
The low target implies +160.4%, while the high target implies +681.3%.
How many analysts are included in BioHarvest Sciences's consensus?
The verified consensus includes 4 analysts.
How is BioHarvest Sciences's target upside or downside calculated?
The average target of $10.50 is divided by the recorded price of $1.92, then one is subtracted to produce +446.9%. This does not guarantee a future return.
When was BioHarvest Sciences's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.